Biologics Spine Cerapedics’ i-FACTOR P-15 Peptide Enhanced Bone Graft, a Trusted Choice in Bone Graft Solutions, Now Approved for Expanded Indications for Use byJosh SandbergSeptember 24, 2024
Biologics Top Stories Biogennix Announces Publication of a Scientific Study on Its Advanced Bone Graft Technology byTim AllenJune 12, 2024
Biologics Regulatory Spine Top Stories Ventris Medical Receives 510(k) Additional Clearance for Amplify® Standalone Bone Graft Putty byJosh SandbergMarch 13, 2024
Regulatory Spine Top Stories SurGenTec® Receives FDA Clearance for OsteoFlo® HydroPutty™, a Hydrophilic Synthetic Bone Graft byJosh SandbergMarch 7, 2024
Biologics Spine Top Stories Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion byJosh SandbergJanuary 4, 2024
Biologics Spine Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia byJosh SandbergApril 11, 2023
Biologics Top Stories Induce Biologics Announces Launch of NMP Cancellous Strips byJosh SandbergFebruary 28, 2023
Biologics Top Stories Comparing the Cellular Effects of Bone Graft Materials: Nanosurfaces vs. Bioglass byJosh SandbergFebruary 22, 2023